Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China flag China · Delayed Price · Currency is CNY
46.26
-2.25 (-4.64%)
At close: Nov 13, 2026

SHE:301075 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
152.8885.28262.13405.27425.76610.93
Trading Asset Securities
15020.04141.6877.5780-
Cash & Short-Term Investments
302.88105.32403.81482.84505.76610.93
Cash Growth
--73.92%-16.37%-4.53%-17.21%484.67%
Accounts Receivable
81.5587.89107.9485.5192.3100.33
Other Receivables
4.9317.0919.5511.27.882.28
Receivables
86.47104.98127.4996.7100.18102.6
Inventory
108.6283.5445.8533.1332.779.82
Prepaid Expenses
--00.050.060.06
Other Current Assets
29.5935.2353.6136.238.665.64
Total Current Assets
527.57329.06630.75648.95647.43729.05
Property, Plant & Equipment
702.18694.53652.8209.8110.68103.41
Long-Term Investments
99.8110.99108.18155.36112.62-
Goodwill
18.6218.719.223.69--
Other Intangible Assets
60.4976.6478.4834.1921.2416.85
Long-Term Deferred Tax Assets
0.33.493.091.250.780.65
Long-Term Deferred Charges
0.342.012.842.70.331.46
Other Long-Term Assets
52.9747.839.6416.335.8-
Total Assets
1,4621,2831,5351,072898.87851.42

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
96.2977.2958.1426.7712.1323.01
Accrued Expenses
4.027.6398.5813.0910.46
Short-Term Debt
34.62229.47275.5450.13100.0620
Current Portion of Long-Term Debt
171108.14115.2111.01--
Current Portion of Leases
-2.223.030.60.290.48
Current Income Taxes Payable
0.61-1.262.411.352.87
Current Unearned Revenue
8.697.552.785.084.163.72
Other Current Liabilities
331.269.8444.4124.613.492.25
Total Current Liabilities
646.49442.14509.37129.18144.5762.79
Long-Term Debt
-88.5137.5118.08--
Long-Term Leases
1.783.737.210.310.88-
Long-Term Unearned Revenue
99.19105.02106.92.12--
Long-Term Deferred Tax Liabilities
20.120.2920.540.9--
Total Liabilities
767.56659.67781.52250.59145.4562.79

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
808080808080
Additional Paid-In Capital
559.22506.89506.94509.22509.5520.5
Retained Earnings
16.237.47109.64182.17163.32192.42
Treasury Stock
--20.99-20.99---
Comprehensive Income & Other
1.141.141.140.68-1.3-
Total Common Equity
656.6574.51676.73772.06751.53792.92
Minority Interest
38.149.0376.7449.611.89-4.28
Shareholders' Equity
694.7623.54753.47821.68753.41788.63
Total Liabilities & Equity
1,4621,2831,5351,072898.87851.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
207.4432.06538.5180.12101.2420.48
Net Cash (Debt)
95.48-326.74-134.69302.72404.53590.45
Net Cash Growth
----25.17%-31.49%750.31%
Net Cash Per Share
1.20-4.13-1.703.855.139.05
Filing Date Shares Outstanding
79.9978.9678.96808080
Total Common Shares Outstanding
79.9978.9678.96808080
Working Capital
-118.92-113.07121.38519.77502.85666.26
Book Value Per Share
8.217.288.579.659.399.91
Tangible Book Value
577.48479.17579.04734.19730.29776.06
Tangible Book Value Per Share
7.226.077.339.189.139.70
Buildings
-530.63506.96167.55117.46103.71
Machinery
-259.16251.45126.263.4760.37
Construction In Progress
-64.095.679.083.940.36